tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Cash flow

113 Followers

Sinovac Biotech Cash Flow

SVA's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, SVA's free cash flow was decreased by $738.05M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
-$ 104.00M$ -770.75M$ 15.35B$ 479.31M$ 39.07M
Investing Cash Flow
-$ -2.92B$ -5.76B$ -3.02B$ -204.76M$ -42.45M
Financing Cash Flow
-$ -76.06M$ -241.40M$ -1.90B$ 592.57M$ 1.74M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-$ 1.28B$ 4.29B$ 11.62B$ 1.05B$ 155.88M
Income Tax Paid Supplemental Data
--$ 1.32B$ 1.49B$ 11.17M$ 7.31M
Interest Paid Supplemental Data
-$ 5.35M$ 1.11M$ 2.80M$ 1.04M$ 717.00K
Issuance Of Capital Stock
-$ 676.00K-$ 1.03M$ 2.00M$ 0.00
Issuance Of Debt
-$ 243.09M$ -2.83M$ -12.81M$ 43.39M$ 3.57M
Repayment Of Debt
-$ -308.00K$ -2.98M$ -33.44M$ -10.39M$ -3.31M
Free Cash Flow
-$ -41.65M$ -779.71M$ 14.63B$ 351.66M$ 28.45M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Sinovac Biotech Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis